You have several options for MS care across Illinois, from Chicago-area academic clinics to regional neurology centers, and this page helps you compare them so you can find the best fit for your needs. Consider factors like provider experience, clinic location, and services offered at centers such as Consultants in Neurology MS Center, Loyola University of Chicago MS Clinic, Northwest Neurology MS Center, Northwestern Medicine Div of MS and Neuroimmunology, and OSF HealthCare Illinois Neurological Institute as you evaluate where to seek care.
13 MS treatment centers32 active clinical trials10 providers with Medicare prescribing dataTop centers in Chicago and statewide
Center types in Illinois
Academic MS Center (7)
Regional Neurology Group (2)
Dedicated MS Practice (2)
Community Hospital Program (1)
Boutique MS Practice (1)
Filter by type:
54% of MS centers in Illinois are classified as Academic MS Center facilities.
Centers with Most Active Trials in Illinois
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
2. Shirley Ryan AbilityLab8 trials
Largest Care Teams in Illinois
1. Endeavor Health MS Program8 providers
2. Northwest Neurology MS Center1 provider
MS Care by City
Active MS clinical trials in Illinois
See all 46 MS trials in Illinois →ActivePhase 2
A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Eli Lilly and Company
Northbrook
ActivePhase 4
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals
Winfield
ActivePhase 3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Novartis Pharmaceuticals
Chicago · Northbrook
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Chicago
ActivePhase 3
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
TG Therapeutics, Inc.
Northbrook
ActivePhase 3
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Immunic AG
Northbrook












